Culture of Quality - Ajaz Hussain
Transcript of Culture of Quality - Ajaz Hussain
Dr. M. VenkatDr. M. Venkat
Indian Pharma Inc. : AIndian Pharma Inc. : A
June 2015 IPA Convention 20
teswarlu Memorial Lectuteswarlu Memorial Lectu
Culture of QualCulture of Qualdapting to the Rapidly Evolving Global Challedapting to the Rapidly Evolving Global Challe
015, BKC, Mumbai
Pharmacy to the World” isdiadiaPharmacy to the WorldPharmacy to the World
Strengthen Strengthen our culture our culture of qualityof quality
Health Care for All –Leadership in setting
the standards for Integrative Medicine, of qualityof qualityleveraging the Wisdom Traditions.
1144
Affordability - Patient f d i llO li d d
2233
focused, continually improving system
based on deep understanding &
integrating engineering &
One quality standard -‘Do No Harm’ to
‘Providing a Healing Touch’ – “India Pharma Brand Identity – Made
in India Proudly”
June 2015 IPA Convention 20
engineering & statistics.
in India, Proudly .
Pharmaceutical Factory to the WorldPharmaceutical Factory to the World
the right aspiration for
Purpose of this talk is to request you toPurpose of this talk is to request you toPurpose of this talk is to request you to Purpose of this talk is to request you to consider the following 4 Steps consider the following 4 Steps
•• Strengthening the ‘Culture of Quality’ Strengthening the ‘Culture of Quality’ –– the the f f thi t lkf f thi t lkfocus of this talkfocus of this talk
• Improve efficiency with confidence in controls by integrating India’s engineering and statistical know-how and technologiesknow how and technologies
• Working together – ‘One Quality for All’ to say proudly – Made in India: Pharmaceutical Factory Pharmaceutical Factory the Worldthe World
• Leverage India’s Wisdom Traditions to provide leadership in setting the standards for IntegrativeMedicine so as to deliver a model of ‘Health Carefor All’: Pharmacy to the WorldPharmacy to the World
015, BKC, Mumbai
for All : Pharmacy to the WorldPharmacy to the World
actory of the world’ thenactory of the world then
India in 2020: the factory of the worldIndia in 2020: the factory of the world
• Ansuya Harjani | Wednesday, 3 Sep 2014;y j | y, p ;•http://www.cnbc.com/id/101966191
'It is now India's turn to sustain Asia's'It is now India's turn to sustain Asia's
• Narendra Modi | May 23, 2015•http://wap.business-standard.com/article/opinion/it-is-now-india-s-turn-to-susta
Pharmacy Vs. Factory - is there a diffePharmacy Vs. Factory - is there a diffe
• Journey to 2020 would benefit from clar
June 2015 IPA Convention 20
‘Pharmacy to the World’Pharmacy to the World
d? d?
; ;
success‘ success‘
ain-asia-s-success-115052300806_1.html
erence? YES.erence? YES.
ity of the vision
015, BKC, Mumbai
ndia is set to become the020a Shivkumar, The Hindu, April 17, 2013
In the immediate – short term, until 2020, industrthe work force it needs to be the ‘pha
With 64 per cent of
the work-force it needs to be the pha
By 2020, India is set to become
the world’s t
With 64 per cent of its population in the working age group.
youngest country Median age in India
will be 29 years.
In parallel, a strong focus on institutional recoveryto be the ‘Pharmac
June 2015 IPA Convention 20
e youngest country by
y will need to take-on ‘skills development’ for armaceutical factory to the world’!armaceutical factory to the world !
• Institutional recoverwill have to be its topmost priority
• Quality of teachers a
The impact of The impact of institutional decay. institutional decay. Krishna Kumar, The Hindu, 15 • Quality of teachers a
all levelsSeptember 2014
y to excellence critical to realize the aspiration cy to the World’
015, BKC, Mumbai
NDIA’S SCIENCE TEST V P d 14 MAY 2015 | VOL 521 | NATUREV. Padma, 14 MAY 2015 | VOL 521 | NATURE
h i i i h ih i i i h iThe Mars mission experience has once again strThe Mars mission experience has once again str
pharmacy of the developing world”pharmacy of the developing world”
…great strides in research and development…great strides in research and development, , bubu
Lack of even bare, minimal and sustainable funds for teachingLack of even bare, minimal and sustainable funds for teachingandards of science education,” andards of science education,” Krishna Ganesh, Director of the
Here [state universities], there are no good science teachers, nHere [state universities], there are no good science teachers, ne poorly equipped”e poorly equipped”
There is overThere is over--bureaucratization within the universitiesbureaucratization within the universities
WE ARE CAUGHT IN A VICIOUS CIRCLE OF MEDIOCRITY” WE ARE CAUGHT IN A VICIOUS CIRCLE OF MEDIOCRITY” - De
Often the appointed person has never been exposed tOften the appointed person has never been exposed tebastian, Chair of the science-education panel of the Indian Acade
June 2015 IPA Convention 20
h d b li f hh d b li f hrengthened our belief that we can.”rengthened our belief that we can.”
ut it has a long way to go.”ut it has a long way to go.”
g, let alone research, has seriously plagued the quality and g, let alone research, has seriously plagued the quality and Indian Institute of Science Education and Research in Pune.
no good Indian textbooks, and most of the science laboratorno good Indian textbooks, and most of the science laborator
s and their controlling bodies” s and their controlling bodies”
epak Pental, former vice-chancellor, the University of Delhi.
to a good university in India or abroad,” to a good university in India or abroad,” Kizhakeyilemy of Sciences in Bangalore.
015, BKC, Mumbai
ackground: India Pharmaackground: India Pharma
The narrative on India The narrative on India Pharmaceutical SectorPharmaceutical Sector
20052005
Current stateCurrent state
Looking forward to 2020
Looking forward to 202020202020
June 2015 IPA Convention 20
Independence-2005: Independence-2005: pNonexistent to a World Leader
pNonexistent to a World Leader
l b l l l lGlobal sales: Value 1%, Volume 8%; ranking: 4 in volume, 13 in value
Continued growth and challenges to ‘Brand Identity’
What will ensure growth that justifies the claim of ‘Pharmacy
015, BKC, Mumbai
to the World’?
ackground: 2005 a speciaackground: 2005 a specia
June 2015 IPA Convention 20
al yearal year
February 25, 2005, February 25, 2005, Mumbai Mumbai The The ISPE ISPE IndiaIndia-- US US FDA FDA PAT PAT forum….forum….
Sharing the stage Sharing the stage with…with…Dr MDr M VenkateswarluVenkateswarlu
015, BKC, Mumbai
Dr. M. Dr. M. Venkateswarlu, Venkateswarlu, then Deputy DCGIthen Deputy DCGI
ackground: My viewpointackground: My viewpoint
ViewView
Building successful bgenerics, biosimila
Building successful bgenerics, biosimila
Reconnecting with IInd
Reconnecting with IInd
Way forward to Way forward to yy
June 2015 IPA Convention 20
on Culture of Qualityon Culture of Quality
point in 2005point in 2005
business models for complex ars, plant-based vaccines,..business models for complex ars, plant-based vaccines,..
India and current practice in dia: “Dil Se”India and current practice in dia: “Dil Se”
2020: Culture of Quality2020: Culture of QualityQ yQ y
015, BKC, Mumbai
y Viewpoint in 2005: As ay Viewpoint in 2005: As a
With increased complexity the current approacp y ppssurance are untenable
Need a effective methodology for QbD and forgy Qust tests and SOP’s
ncorrect focus on compendial tests and their uction mode”; continual improvement unlikely
An integrated approach (e.g., PAT Team) to regi l iontinual improvement.
We must transform our education system fromi ingineering
June 2015 IPA Convention 20
a regulatora regulator
ch to development, manufacturing and qualityp , g q y
r a focus on in –process controls as opposed tp pp
use for lot-release keeps the system in ‘correctwithin this mindset.
ulatory oversight is necessary to move toward
m ‘Industrial Pharmacy’ to Pharmaceutical
015, BKC, Mumbai
iewpoint 2005: As a reguliewpoint 2005: As a regulThe Nation Needs a CoPh i l E iVIEWPOINT 2005 Pharmaceutical EngineeResearch System
“A recent re‐examinationAdministration of the cur
VIEWPOINT 2005
fdecision‐making system rabout its efficiency andto address the increasinpharmaceutical systemp y“….low success rate foof deviations and out‐oas well as the predomintesting—often based ontesting often based onconsideration of inhereprocess conditions—wfacilitate regulatory documvalidation ”
June 2015 IPA Convention 20
validation.Pharmaceutical Technology SEPTEMBER 2005
atoratormprehensive i Ed i dering Education and
n by the US Food and Drug rrent pharmaceutical quality
“And like the heroes of the French Revolution, we look to a future
p q yraised fundamental questions d its continuing effectiveness ng complexity of ms.”
that will bring us everything or
nothing, depending on the public trust”
or identifying the root cause of‐specification observations nant focus on end‐product n an inadequate statisticaln an inadequate statistical ent variability and static which, some argue, evolved to ment expectations for “process
015, BKC, Mumbai 1
005 onwards, amazing opewpoint 2015ewpoint 2015
VP & Global Head Biopharmaceutical Development, SandozVP & Global Head Biopharmaceutical Development, Sandoz
Biosimilars & complex generics
VP Next Generation Product Assessment and hen Chief Scientific Officer at Philip Morris
VP Next Generation Product Assessment and hen Chief Scientific Officer at Philip Morris pnternational
pnternational
Plant based vaccines & Modified Risk Tobacco Products
President Biotechnology & Chief Scientific Officer t Wockhardt Ltd
President Biotechnology & Chief Scientific Officer t Wockhardt Ltd
Understanding the aspirations opportunities and challengesUnderstanding the aspirations, opportunities and challenges in India
June 2015 IPA Convention 20
pportunities to expand my
015, BKC, Mumbai 1
Way forward to 2020Way forward to 2020
June 2015 IPA Convention 20
Culture Culture of of QualityQuality
015, BKC, Mumbai 1
What is Quality?What is Quality?
June 2015 IPA Convention 20
MMedicine made correctly whenedicine made correctly when
no one is lookingno one is lookingno one is looking.no one is looking.
015, BKC, Mumbai 1
When is medicine When is medicine mademade correctly?correctly?made made correctly?correctly?
June 2015 IPA Convention 20
Our collective consensus, based on sciencOur collective consensus, based on sciencobjectively determines what are the good objectively determines what are the good practices practices –– capability, capacity and capability, capacity and commitment to practice when no one iscommitment to practice when no one iscommitment to practice when no one is commitment to practice when no one is looking.looking.
015, BKC, Mumbai 1
When medicine isWhen medicine isWhen medicine is When medicine is not made not made correctly…correctly…
June 2015 IPA Convention 20
People People get sick. Some get sick. Some die. die. It is hard to It is hard to detectdetect harmharm Some of these people areSome of these people aredetect detect harm. harm. Some of these people are Some of these people are already very vulnerable, and proving the already very vulnerable, and proving the cause of harm from impurities, adulterationcause of harm from impurities, adulterationand counterfeits can be elusive. and counterfeits can be elusive. Congressman ShimkusCongressman Shimkus
015, BKC, Mumbai 1
19891989
19371937
19621962
19891989
19371937
FD&C Act FD&C Act Kefauver-Harris Kefauver-Harris 1984 Drug Prand Patent Te1984 Drug Prand Patent Te
A partial, historical, ‘snap-shot’ of the US F
June 2015 IPA Convention 20
20122012
20072007Proactive risk Proactive risk
classification & classification & mitigation mitigation
needed needed
rice Competition erm Restoration Actrice Competition erm Restoration Act FDASIAFDASIA ……………….……………….
FD&C Act
015, BKC, Mumbai 1
With increasing With increasing complexitycomplexitycomplexity…complexity…
June 2015 IPA Convention 20
Mistakes cost more lives. Path to success must be built on trustworthiness so as to proudly proclaim to the world we (a company) make the medicine you confidencompany) make the medicine you confidengive to your child!
015, BKC, Mumbai 1
What is Culture What is Culture of of Quality?Quality?Quality?Quality?
June 2015 IPA Convention 20
Knowledge, beliefs, values, Knowledge, beliefs, values,
t diti b h i dt diti b h i d tititraditions, behaviors and traditions, behaviors and practices practices
that give confidence that medicine that give confidence that medicine
made made correctly when no one is correctly when no one is
looking.looking.
015, BKC, Mumbai 1
When When no one is no one is ooking?ooking?ooking?ooking?
June 2015 IPA Convention 20
Our intention guides our Our intention guides our
behaviorbehaviorbehavior.behavior.
015, BKC, Mumbai 1
We are humansWe are humans
June 2015 IPA Convention 20
Our thoughts and beliefs areOur thoughts and beliefs are
powerful and influence our
actions and also outcomes.
015, BKC, Mumbai 2
Placebo effect:Placebo effect:Placebo effect: Placebo effect: A study A study ublished in 2015 “opens ublished in 2015 “opens our eyes to another our eyes to another uance of placebo effect with implications for uance of placebo effect with implications for inical practice the research enterprise andinical practice the research enterprise andinical practice, the research enterprise, and inical practice, the research enterprise, and ealth ealth policy”. policy”. Editorial Neurology 84: Editorial Neurology 84: 20152015
June 2015 IPA Convention 20
““perceptionsperceptions of cost are capabof cost are capabperceptions perceptions of cost are capabof cost are capab
of altering the placebo responsof altering the placebo respons
in clinical studiesin clinical studies.” .” Neurology 84: 20Neurology 84: 20
015, BKC, Mumbai 2
lso, as humans lso, as humans “we “we cancanbvious, and we are alsobvious, and we are alsolindnesslindness.”.”
Daniel Kahneman,
Thinking, Fast and Slow
June 2015 IPA Convention 20
n be blind to the n be blind to the o blind to our o blind to our
015, BKC, Mumbai 2
http://web.mit.edu/persci/people/adelson/checkershadow_proof.h
o these questions contio these questions contiompany Xompany X??ompany Xompany X??
What is pharmaceutical quality?
Compendial testing sufficient?
Process validation – representativ
Deviation from cGMP means the
June 2015 IPA Convention 20
inue to linger in inue to linger in
ve of commercial manufacturing?
product is ‘adulterated’?
015, BKC, Mumbai 2
k of unintended or inten‘testing into compliance
Process validation is
done so quality is
dattitude toward
performing
good;
test prone to errorperforming
the behaviorerror
“Batch failure means I made a mistake”
“T ti i t li ”“T ti i t li ”
/14/2015 CONFIDENTIAL – ©INSIGHT ADVICE &
“Testing into compliance”“Testing into compliance”
nded normative supportppe’?
Documennot critic
subjective norm
Compendtestingnorm g
sufficien
Local regulatoregulato
collect & tsamples –issue ther
””
© AJAZ S. HUSSAIN | & SOLUTIONS LLC 2
””
Latent Latent अूकट अूकट conditions conditions
Fear of errorFear of error
Design flawsDesign flaws
Techno
ErrorError
(Constra
“We cannot change the human condition. Bhumans work” James Reason
June 2015 IPA Convention 20
humans work James Reason
Goal conflicts & mixed messagesGoal conflicts & mixed messagesProduction pressuresProduction pressuresProduction pressuresProduction pressures
O i iOrganization (Policies & Sr. Mgmt.)
Team & Supervisor (Soft Defenses)
ology
Individual (Training & Certification)
DefensesDefenses(Quality Management System)(Quality Management System)
aints & Controls)
But…we can change the conditions under which
015, BKC, Mumbai 2
H ldH ldHow would you How would you respond to this respond to this t t t?t t t?statement?statement?
At many Pharma companiesAt many Pharma companiesAt many Pharma companies At many Pharma companies in India] in India] the the staff would feel staff would feel
afraid to question afraid to question a a upervisor’supervisor’s order even whenorder even whenupervisor’s upervisor’s order even when order even when hey know hey know for sure for sure that the that the upervisor’s order is not in upervisor’s order is not in the the t tt t f ti tf ti tnterest nterest of patients.of patients.
I cwi
June 2015 IPA Convention 20
I disagree with this statement
15.21
9.943.4 N=263Skipped = 0
14.1
17 517.5
completely agree ith this statement
015, BKC, Mumbai 2
ow would you ow would you respond respond this statement? this statement?
think management think management houldhould urgently workurgently workhould hould urgently work urgently work owards making owards making rror/mistakerror/mistakerror/mistakerror/mistakeeporting eporting ormal, Easy and ormal, Easy and ewarding.ewarding.
It isthi
June 2015 IPA Convention 20
this
It is already easy soIt is already easy – so this is not urgent.
5.86.6
[VALUE]
17.4
[VALUE]
N=259Skipped =4
32.8
s very difficult currently so i t t i
015, BKC, Mumbai 2
s is very urgent topic
redictors of CoQ: Act consatients – when no one is latients when no one is l
Leadership Emphasis
Only four attributes
ll d
Only four attributes
ll d
Message Credibility
actually predict a culture of
quality:
actually predict a culture of
quality: Peer Involvement
Employee Empowerment
June 2015 IPA Convention 20
sciously in the interest of ookingooking.
N l (1)
People will change their
b h f h
People will change their
b h f h
Normal (1)
behavior if they see the new behavior as
behavior if they see the new behavior as
Easy (2)
Rewarding (3)
015, BKC, Mumbai 2
simple framework for CoQsimple framework for CoQ
EnvironmentEnvironment Leadership EmphasisLeadership Emphasis Message CredMessage Cred
Culture of
Normal
Easy QMSQuality
Rewarding
Q
Dem
June 2015 IPA Convention 20
& Ja
dibilitydibility Peer InvolvementPeer Involvement Employee EmpowermentEmployee Empowerment
Systemy
KnowledgeBehavior
GXPs
Fear Removed
Mastery
Variation
Behavior
- GXPs
Awarenes
ming’s Profound Knowledge
015, BKC, Mumbai 2
g games Reasons – Human Factors
Systems thinking: System is the product of ink t l ill t i th t aken separately will not improve the system
Quality Quality
CEO & Managers & All
June 2015 IPA Convention 20
Sr. Management Leaders Employees
nteracting parts; improving the parts
is Easy is Easy
Culture Effective GXP
015, BKC, Mumbai 3
of QualityQMSCompliance
June 2015 IPA Convention 20015, BKC, Mumbai 3
Not so highly Not so highly regulated”regulated”gg
Export qualityExport qualityp q yp q y
Highly regulated” Highly regulated” g y gg y g
June 2015 IPA Convention 20
“Pharmacy to the World”“Pharmacy to the World”
Domestic qualityDomestic quality
St d d Hi hlSt d d Hi hlStandard = Highly Standard = Highly
RegulatedRegulatedRegulated Regulated
015, BKC, Mumbai 3
llopathy: Export quality =llopathy: Export quality
f not - why should any one believe that,ooking, quality is delivered as promised
The argument – that “affordabilitylit t d d i k i d fquality standards is weak, indefen
from the aspiration to be “pharma
Commitment to a single quahumans – is a measure of cu
June 2015 IPA Convention 20
Domestic qualityDomestic quality
, when no one is ?
y” demands two ibl d t ksible and takes away
acy to the world”.
ality standard – we are all ulture of quality.
015, BKC, Mumbai 3
ince 2000 organizations beceived the most Demingeceived the most Deming
0
5
Deming Prizes since 2000http://blog.deming.org/2014/10/2014-deming-prize-awardees/
5
0
5
0
0
June 2015 IPA Convention 20
based in India have PrizesPrizesWhat does it take to win the “Deming Prize”?
•Commitment to Total Quality Management•The foundation is total employee involvement!
• Attrition rates 25-50%; primarily in QC/QA departments; why? Is the fear level so high?
Where are we today in India Pharma?
• How effective is their training in college? At the company? How effective are supervisors in coaching and mentoring techniques?
• How effective are the HR systems to mitigate the effects of “Saala main to sahab ban gaya” attitudes in someSaala main to sahab ban gaya attitudes in some supervisors and senior management?
• Why 483 Observations are often not shared with the employees?
• How many Sr. Management truly understand what is quality
015, BKC, Mumbai 3
How many Sr. Management truly understand what is quality – and are their messages credible?
mpower professionals, give tdia the ‘pharmacy to the wordia the pharmacy to the wor
There is amazing taleThere is amazing tale
Urgent need for moreUrgent need for moreU ge t eed o o ementoring – to removU ge t eed o o ementoring – to remov
Within India, but outs“quality revolution” inclass quality’ is right
Within India, but outs“quality revolution” inclass quality’ is rightclass quality is right class quality is right
June 2015 IPA Convention 20
them the challenge to make rld’; slogans will not do itrld ; slogans will not do it.
ent & commitment to hard work ent & commitment to hard work
e effective training, coaching and e effective training, coaching and e e ect e t a g, coac g a dve fear and to empowere e ect e t a g, coac g a dve fear and to empower
side Pharma, there is an ongoing n some sectors; knowhow for ‘world here
side Pharma, there is an ongoing n some sectors; knowhow for ‘world herehere here
015, BKC, Mumbai 3
nowhow for ‘world class qnowhow for world class q
June 2015 IPA Convention 20
quality’ is right herequality is right here
015, BKC, Mumbai 3
iewpoint 2015 “Dil Se”iewpoint 2015 Dil Se
VIEWPOINT 2015
June 2015 IPA Convention 20
To remain true to ‘first do no harm’ we, the legitimate pharmaceutical community havelegitimate pharmaceutical community, have inherited, and accepted, a culture of quality that demands that our intention, our awareness and our skills deliver ‘quality by design’ with continued vigilance to detect, correct and to prevent errors that have caused, or have the potential to cause, harm to the patients we serve. We also recognize thepatients we serve. We also recognize the limitations of our pharmacovigilance.
We must more clearly recognize that CAPA is not ‘continual improvement’ and that wenot continual improvement and that we must strengthen our culture of quality to deliver continual improvement in our ability to assure quality, reduce costs and enhance fid i h t d
015, BKC, Mumbai 3
confidence in what we do. Ajaz S. Hussain, Ph.D., Mumbai, 24 March 2015
iewpoint 2015 “Dil Se” toiewpoint 2015 Dil Se to
In the immediateIn the immediate –– short term ushort term uIn the immediate In the immediate short term, ushort term, uto taketo take--on ‘skills development’ foon ‘skills development’ fobe the ‘pharmaceutical factory tobe the ‘pharmaceutical factory top yp y
In parallel, a strong focus onIn parallel, a strong focus onexcellence critical to realize texcellence critical to realize texcellence critical to realize texcellence critical to realize t‘Pharmacy to the World’!‘Pharmacy to the World’!
June 2015 IPA Convention 20
SolutionsSolutions
ntil 2020 industry will needntil 2020 industry will needntil 2020, industry will need ntil 2020, industry will need or the workor the work--force it needs to force it needs to o the world’! o the world’!
institutional recovery to institutional recovery to the aspiration to be thethe aspiration to be thethe aspiration to be the the aspiration to be the
015, BKC, Mumbai 3
rmacy to the World”: A champion forrmacy to the World”: A champion for
Health Care for All –
Pharmacy to the WorldPharmacy to the World 11
Strengthen Strengthen our culture our culture of qualityof quality
Health Care for All Leadership in setting the standards for Integrative Medicine, leveraging the
Wisdom Traditions.
11
2233
44
Affordability - Patient focused, continually
improving system based
One quality standard -‘Do No Harm’ to
‘Providing a Healing
2233
improving system based on deep understanding
& integrating engineering & statistics.
Providing a Healing Touch’ – “India Pharma
Brand Identity – Made in India, Proudly”.
Pharmaceutical Factory to the WorldPharmaceutical Factory to the World
June 2015 IPA Convention 20
yy
•• Leadership emphasisLeadership emphasis
ReRe--shaping the Environmentshaping the Environment
p pp p•• Message credibilityMessage credibility•• Peer involvementPeer involvement•• Employee empowermentEmployee empowerment
•• Quality is normalQuality is normal•• Quality is easyQuality is easy
ReRe--setting the Normssetting the Norms
•• Quality is rewardingQuality is rewarding
Commitment to the SystemCommitment to the System
Ensuring effective QMSEnsuring effective QMS
•• Commitment to the SystemCommitment to the System•• Knowledge basedKnowledge based•• Understanding & controlling variationsUnderstanding & controlling variations•• SafeSafe--guard human error; pride of workmanshipguard human error; pride of workmanship
•• Fear removedFear removed•• MasteryMastery
Promoting proactive behaviorsPromoting proactive behaviors
015, BKC, Mumbai 3
MasteryMastery•• Awareness Awareness